Related Experiment Video
Updated: Jun 3, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Renal denervation and hypertension
Markus P Schlaich1, Henry Krum, Paul A Sobotka
1Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, Australia.
Insights
Renal denervation, a novel procedure using radiofrequency energy to disrupt renal nerves, shows promise for managing difficult-to-treat hypertension. Further research is needed to fully understand its potential and risks for blood pressure control.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Interventional Cardiology
Background:
- Essential hypertension is a major global health challenge requiring multifactorial therapeutic strategies.
- Current treatments, including lifestyle changes and combination pharmacotherapy, are insufficient for many patients, leaving them at high cardiovascular risk.
- The role of renal sympathetic nerves in blood pressure regulation necessitates exploring new therapeutic avenues.
Purpose of the Study:
- To review the scientific basis of renal denervation for hypertension management.
- To summarize current evidence on the safety and efficacy of renal nerve ablation.
- To identify and discuss unresolved questions regarding this interventional approach.
Main Methods:
- Review of preclinical and clinical data on renal sympathetic nerve activity in blood pressure control.
- Analysis of outcomes from studies involving catheter-based radiofrequency (RF) renal denervation.
- Discussion of existing evidence regarding the safety profile and blood pressure reduction associated with the procedure.
Main Results:
- Renal denervation utilizes RF energy to selectively target and disrupt renal sympathetic nerves.
- Preliminary data from uncontrolled studies suggest a favorable safety profile for renal denervation.
- The procedure is associated with substantial and potentially sustained reductions in blood pressure.
Conclusions:
- Renal denervation presents a promising new therapeutic option for managing resistant hypertension.
- While initial results are auspicious, further research is crucial to address numerous unanswered questions.
- Continued investigation is required to fully elucidate the potential benefits and risks of renal nerve ablation.
Abstract:
Essential hypertension remains one of the biggest challenges in medicine with an enormous impact on both individual and society levels. With the exception of relatively rare monogenetic forms of hypertension, there is now general agreement that the condition is multifactorial in nature and hence requires therapeutic approaches targeting several aspects of the underlying pathophysiology. Accordingly, all major guidelines promote a combination of lifestyle interventions and combination pharmacotherapy to reach target blood pressure (BP) levels in order to reduce overall cardiovascular risk in affected patients. Although this approach works for many, it fails in a considerable number of patients for various reasons including drug-intolerance, noncompliance, physician inertia, and others, leaving them at unacceptably high cardiovascular risk. The quest for additional therapeutic approaches to safely and effectively manage hypertension continues and expands to the reappraisal of older concepts such as renal denervation. Based on the robust preclinical and clinical data surrounding the role of renal sympathetic nerves in various aspects of BP control very recent efforts have led to the development of a novel catheter-based approach using radiofrequency (RF) energy to selectively target and disrupt the renal nerves. The available evidence from the limited number of uncontrolled hypertensive patients in whom renal denervation has been performed are auspicious and indicate that the procedure has a favorable safety profile and is associated with a substantial and presumably sustained BP reduction. Although promising, a myriad of questions are far from being conclusively answered and require our concerted research efforts to explore the full potential and possible risks of this approach. Here we briefly review the science surrounding renal denervation, summarize the current data on safety and efficacy of renal nerve ablation, and discuss some of the open questions that need to be addressed in the near future.
Related Concept Videos
Hypertension II: Pathophysiology
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Action of β1 Blockers
